Fig. 4From: A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinomaKaplan-Meier analysis of overall survival based on the combination of TP53 mutation status and risk score of the prognostic model. A TP53 mutation vs wildtype group. B TP53 mutation status with high−/low-risk group. C TP53 mutation subgroup with high−/low-risk group. D TP53 wildtype subgroup with high−/low-risk groupBack to article page